Lafayette Investments’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8K | Hold |
13,000
| – | – | ﹤0.01% | 150 |
|
|
2025
Q1 | $5.87K | Hold |
13,000
| – | – | ﹤0.01% | 146 |
|
|
2024
Q4 | $6.53K | Hold |
13,000
| – | – | ﹤0.01% | 149 |
|
|
2024
Q3 | $11.8K | Hold |
13,000
| – | – | ﹤0.01% | 146 |
|
|
2024
Q2 | $13K | Hold |
13,000
| – | – | ﹤0.01% | 142 |
|
|
2024
Q1 | $19.2K | Hold |
13,000
| – | – | ﹤0.01% | 141 |
|
|
2023
Q4 | $14.2K | Hold |
13,000
| – | – | ﹤0.01% | 135 |
|
|
2023
Q3 | $15.3K | Hold |
13,000
| – | – | ﹤0.01% | 128 |
|
|
2023
Q2 | $18.3K | Hold |
13,000
| – | – | ﹤0.01% | 126 |
|
|
2023
Q1 | $19.5K | Hold |
13,000
| – | – | 0.01% | 124 |
|
|
2022
Q4 | $15.2K | Hold |
13,000
| – | – | ﹤0.01% | 121 |
|
|
2022
Q3 | $15K | Hold |
13,000
| – | – | ﹤0.01% | 117 |
|
|
2022
Q2 | $21K | Hold |
13,000
| – | – | 0.01% | 120 |
|
|
2022
Q1 | $20K | Hold |
13,000
| – | – | 0.01% | 128 |
|
|
2021
Q4 | $32K | Hold |
13,000
| – | – | 0.01% | 125 |
|
|
2021
Q3 | $33K | Hold |
13,000
| – | – | 0.01% | 125 |
|
|
2021
Q2 | $37K | Hold |
13,000
| – | – | 0.01% | 124 |
|
|
2021
Q1 | $31K | Buy |
13,000
+3,000
| +30% | +$7.15K | 0.01% | 90 |
|
|
2020
Q4 | $18K | Buy |
+10,000
| New | +$18K | 0.01% | 87 |
|